These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients. Kyllästinen M, Groop L. Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537 [Abstract] [Full Text] [Related]
3. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE, Matthews DR. Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [Abstract] [Full Text] [Related]
4. Lack of effect of glibenclamide on insulin requirements and diabetic control in persons with insulin-dependent diabetes. Stocks AE, Ma A, Howlett V, Cameron DP. Med J Aust; 1988 Nov 07; 149(9):472-3. PubMed ID: 3141755 [Abstract] [Full Text] [Related]
6. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone. Groop L, Harno K, Nikkilä EA, Pelkonen R, Tolppanen EM. Acta Med Scand; 1985 Nov 07; 217(1):33-9. PubMed ID: 3919531 [Abstract] [Full Text] [Related]
10. Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect. Bieger WP, Dlugosch R, Rettenmeier A, Holler HD, Bert H, Schwarz W, Fiehn W, Merkt J, Weicker H. Klin Wochenschr; 1984 Jul 02; 62(13):631-9. PubMed ID: 6434794 [Abstract] [Full Text] [Related]
11. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects. Riddle MC, Hart JS, Bouma DJ, Phillipson BE, Youker G. Diabetes Care; 1989 Oct 02; 12(9):623-9. PubMed ID: 2507265 [Abstract] [Full Text] [Related]
14. Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes. Burke BJ. Diabetologia; 1985 Mar 02; 28(3):182. PubMed ID: 3922830 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes. Scheen AJ, Jaminet C, Luyckx AS, Lefebvre PJ. Int J Clin Pharmacol Ther Toxicol; 1987 Feb 02; 25(2):70-6. PubMed ID: 3104218 [Abstract] [Full Text] [Related]
16. [Combined treatment of type-2 diabetics with insulin and glibenclamide after secondary drug failure. Double-blind, insulin-placebo-controlled crossover study]. Rosak C, Schwarz O, Althoff PH, Schöffling K, Schmidt FH. Dtsch Med Wochenschr; 1985 Dec 20; 110(51-52):1975-80. PubMed ID: 3935405 [Abstract] [Full Text] [Related]
19. A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy. Wolffenbuttel BH, Weber RF, van Koetsveld PM, Weeks L, Verschoor L. Diabet Med; 1989 Aug 20; 6(6):520-5. PubMed ID: 2527134 [Abstract] [Full Text] [Related]
20. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide. Massi-Benedetti M, Herz M, Pfeiffer C. Horm Metab Res; 1996 Sep 20; 28(9):451-5. PubMed ID: 8911982 [Abstract] [Full Text] [Related] Page: [Next] [New Search]